Near-equivalence in oncology: Generating evidence to support alternative cost-effective treatments
11 Feb, 2021 | 02:02h | UTC
Commentary on Twitter
Thoughtful piece with real implications for decreasing costs and improving access to cancer care – with particular relevance in low- and middle-resource settings although applicable in all settings. https://t.co/MkQx6Gzte4
— Julie Gralow (@jrgralow) February 10, 2021